Literature DB >> 22137678

Physicians' attitudes towards self-treatment of latent tuberculosis.

N Bhanot1, M Haran, A Lodha, V Paul, R Goswami, E K Chapnick.   

Abstract

We conducted a cross-sectional study to assess physicians' attitudes towards self-treatment of latent tuberculosis infection (LTBI) based on real-time responses related to actual purified protein derivative (PPD) results, in addition to using hypothetical situations for those who were PPD-negative. We also obtained information on physicians' recommendations for their patients to treat this condition. Although the physicians claimed to recommend optimal treatment to their patients, the majority of them had different attitudes when considering treatment for themselves. There appears to be a discrepancy between physicians' attitudes to self-treatment and their management of patients with LTBI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22137678     DOI: 10.5588/ijtld.11.0232

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Attitudes towards latent tuberculosis among physicians in training: the role of BCG vaccination.

Authors:  Franklin Yates; Arun Janakiraman; Anna Headly; Darren R Linkin; Christopher Vinnard
Journal:  J Community Health       Date:  2015-04

2.  Attitudes towards preventive tuberculosis treatment among hospital staff.

Authors:  Vidya Pathak; Zinta Harrington; Claudia C Dobler
Journal:  PeerJ       Date:  2016-02-25       Impact factor: 2.984

3.  Beyond pills and tests: addressing the social determinants of tuberculosis.

Authors:  Tom Wingfield; Marco A Tovar; Doug Huff; Delia Boccia; Matthew J Saunders; Sumona Datta; Rosario Montoya; Eric Ramos; James J Lewis; Robert H Gilman; Carlton Evans
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

4.  What patient factors predict physicians' decision not to treat latent tuberculosis infection in tuberculosis contacts?

Authors:  Claudia C Dobler; Queenie Luu; Guy B Marks
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.